Publikation

A comprehensive assessment of ATMP. Difficulties and approaches

Wissenschaftlicher Artikel/Review - 01.07.2011

Bereiche
PubMed
DOI

Zitation
Thanner M, Nagel E. A comprehensive assessment of ATMP. Difficulties and approaches. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2011; 54:843-8.
Art
Wissenschaftlicher Artikel/Review (Deutsch)
Zeitschrift
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2011; 54
Veröffentlichungsdatum
01.07.2011
eISSN (Online)
1437-1588
Seiten
843-8
Kurzbeschreibung/Zielsetzung

Advanced therapy medicinal products (ATMP) are associated with high expectations because they offer new opportunities for the treatment of diseases, e.g., the possibility of regenerating damaged or lost tissue. What the products (gene therapy, somatic cell therapy, and tissue engineered products) have in common is an innovative and complex development process that combines science and engineering. At the same time, this field of research is becoming increasingly interdisciplinary and requires international cooperation. A comprehensive assessment of ATMP has to take these issues into account. The application of Beauchamp and Childress' Four Principles (Principle-Based Ethics) as well as Discourse Ethics as a framework may lead to a broader consideration of medical ethics issues.